OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The regulatory mechanism and potential application of IL-23 in autoimmune diseases
De-Kai Xiong, Xiang Shi, Miaomiao Han, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15

Showing 15 citing articles:

Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies
Farzana Yasmeen, Rameez Hassan Pirzada, Bilal Ahmad, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7666-7666
Open Access | Times Cited: 19

Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments
Karolina Makowska, Joanna Nowaczyk, Leszek Blicharz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 781-781
Open Access | Times Cited: 35

Pharmacogenomic insights: IL-23R and ATG-10 polymorphisms in Sorafenib response for hepatocellular carcinoma
Asmaa Elsheshtawy, Rehab H. Werida, Monir Bahgat, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access

Targeting IL-17 and its receptors: A feasible way for natural herbal medicines to modulate fibroblast-like synoviocytes in rheumatoid arthritis
Qi Liang, Lin He, Jingwen Wang, et al.
Biochemical Pharmacology (2024), pp. 116598-116598
Closed Access | Times Cited: 3

Anti-psoriasis molecular targets and active components discovery of Optimized Yinxieling Formula via affinity-purified strategy
Wei Wang, Lijuan Liu, Zhuo YANG, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 2, pp. 127-136
Closed Access | Times Cited: 2

In vitro identification of single-stranded DNA aptamers targeting human IL-23 using the protein-SELEX strategy
Mohammad Ali Rezaee, Saeideh Sadat Shobeiri, Malihe Moghadam, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 247, pp. 116245-116245
Closed Access | Times Cited: 2

3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility
Bao Khanh Trang, Prabhat Sharma, Laura Cook, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis
Xiaojiao Li, Bing Li, De‐Ming Yang, et al.
JAMA Dermatology (2024)
Closed Access | Times Cited: 1

Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries
Margherita Sisto, Sabrina Lisi
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5699-5699
Open Access | Times Cited: 3

A Novel Human Interleukin‐23A Overexpressing Mouse Model of Systemic Lupus Erythematosus
Eleni Christodoulou‐Vafeiadou, Christina Geka, Lida Iliopoulou, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 7, pp. 1085-1095
Open Access

Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-interleukins
Seung Min Hong, Won Moon
Korean Journal of Gastroenterology (2024) Vol. 84, Iss. 2, pp. 65-81
Open Access

Interleukins Signature Profile in the Etiopathogenesis of Oral Submucous Fibrosis: A Comprehensive Study
Roopa Yadahalli, Gargi S. Sarode, Sachin C. Sarode, et al.
Medical Journal of Dr D Y Patil Vidyapeeth (2024) Vol. 17, Iss. Suppl 1, pp. S37-S45
Open Access

Research Progress of Biologics in the Treat-ment of Psoriasis and Related Skin Diseases
子芝 魏
Advances in Clinical Medicine (2023) Vol. 13, Iss. 06, pp. 10240-10247
Closed Access

Page 1

Scroll to top